BVS Bioventus Inc

USD 7.36 0.19 2.64993
Icon

Bioventus Inc (BVS) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 7.36

+0.19 (+2.65)%

USD 0.42B

0.36M

USD 8.50(+15.49%)

N/A

Icon

BVS

Bioventus Inc (USD)
COMMON STOCK | NSD
USD 7.36
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.42B

N/A

USD 7.36

Bioventus Inc (BVS) Stock Forecast

Show ratings and price targets of :
USD 8.50
(+15.49%)

Based on the Bioventus Inc stock forecast from 2 analysts, the average analyst target price for Bioventus Inc is USD 8.50 over the next 12 months. Bioventus Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Bioventus Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Bioventus Inc’s stock price was USD 7.36. Bioventus Inc’s stock price has changed by +6.67% over the past week, +29.81% over the past month and +110.29% over the last year.

No recent analyst target price found for Bioventus Inc
No recent average analyst rating found for Bioventus Inc

Company Overview Bioventus Inc

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgica...Read More

https://www.bioventus.com

4721 Emperor Boulevard, Durham, NC, United States, 27703

995

December

USD

USA

Adjusted Closing Price for Bioventus Inc (BVS)

Loading...

Unadjusted Closing Price for Bioventus Inc (BVS)

Loading...

Share Trading Volume for Bioventus Inc Shares

Loading...

Compare Performance of Bioventus Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BVS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bioventus Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -0.01 (-0.01%) USD45.36B 74.06 57.12

ETFs Containing BVS

Symbol Name BVS's Weight Expense Ratio Price(Change) Market Cap
FKU:LSE
First Trust United Kingdo.. 2.46 % 0.00 % +14.75 (+0.48%) USD6.77M

Frequently Asked Questions About Bioventus Inc (BVS) Stock

Based on ratings from 2 analysts Bioventus Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on BVS's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for BVS is USD 8.50 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on BVS's stock to indicate if its overvalued.

The last closing price of BVS's stock was USD 7.36.

The most recent market capitalization for BVS is USD 0.42B.

Based on targets from 2 analysts, the average taret price for BVS is projected at USD 8.50 over the next 12 months. This means that BVS's stock price may go up by +15.49% over the next 12 months.

Following are ETFs with the highest allocation to Bioventus Inc's stock :

FKU:LSE

As per our most recent records Bioventus Inc has 995 Employees.

Bioventus Inc's registered address is 4721 Emperor Boulevard, Durham, NC, United States, 27703. You can get more information about it from Bioventus Inc's website at https://www.bioventus.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...